Cargando…
Data for comparative proteomics analysis of the antitumor effect of CIGB-552 peptide in HT-29 colon adenocarcinoma cells
CIGB-552 is a second generation antitumor peptide that displays potent cytotoxicity in lung and colon cancer cells. The nuclear subproteome of HT-29 colon adenocarcinoma cells treated with CIGB-552 peptide was identified and analyzed [1]. This data article provides supporting evidence for the above...
Autores principales: | Núñez de Villavicencio-Díaz, Teresa, Ramos Gómez, Yassel, Oliva Argüelles, Brizaida, Fernández Masso, Julio R., Rodríguez-Ulloa, Arielis, Cruz García, Yiliam, Guirola-Cruz, Osmany, Perez-Riverol, Yasset, Javier González, Luis, Tiscornia, Inés, Victoria, Sabina, Bollati-Fogolín, Mariela, Besada Pérez, Vladimir, Guerra Vallespi, Maribel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4534583/ https://www.ncbi.nlm.nih.gov/pubmed/26306321 http://dx.doi.org/10.1016/j.dib.2015.06.024 |
Ejemplares similares
-
The Antitumor Peptide CIGB-552 Increases COMMD1 and Inhibits Growth of Human Lung Cancer Cells
por: Fernández Massó, Julio R., et al.
Publicado: (2013) -
Proteomic Study to Survey the CIGB-552 Antitumor Effect
por: Rodríguez-Ulloa, Arielis, et al.
Publicado: (2015) -
The Anticancer Peptide CIGB-552 Exerts Anti-Inflammatory and Anti-Angiogenic Effects through COMMD1
por: Daghero, Hellen, et al.
Publicado: (2020) -
Cell Penetrating Capacity and Internalization Mechanisms Used by the Synthetic Peptide CIGB-552 and Its Relationship with Tumor Cell Line Sensitivity
por: Astrada, Soledad, et al.
Publicado: (2018) -
Targeting of Protein Kinase CK2 in Acute Myeloid Leukemia Cells Using the Clinical-Grade Synthetic-Peptide CIGB-300
por: Rosales, Mauro, et al.
Publicado: (2021)